Lebwohl MG - Search Results

1

Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate-to-severe atopic dermatitis: Results from the JAK1 Atopic Dermatitis Efficacy and Safety (JADE) REGIMEN phase 3 trial.

Blauvelt A, Silverberg JI, Lynde CW, Bieber T, Eisman S, Zdybski J, Gubelin W, Simpson EL, Valenzuela F, Criado PR, Lebwohl MG, Feeney C, Khan T, Biswas P, DiBonaventura M, Valdez H, Cameron MC, Rojo R. Blauvelt A, et al. Among authors: lebwohl mg. J Am Acad Dermatol. 2022 Jan;86(1):104-112. doi: 10.1016/j.jaad.2021.05.075. Epub 2021 Aug 17. J Am Acad Dermatol. 2022. PMID: 34416294 Free article. Clinical Trial.

2

A double-blind, vehicle-controlled study of clobetasol propionate 0.05% (Temovate) scalp application in the treatment of moderate to severe scalp psoriasis.

Olsen EA, Cram DL, Ellis CN, Hickman JG, Jacobson C, Jenkins EE, Lasser AE, Lebwohl M, Leibsohn E, Medansky RS, et al. Olsen EA, et al. J Am Acad Dermatol. 1991 Mar;24(3):443-7. doi: 10.1016/0190-9622(91)70069-e. J Am Acad Dermatol. 1991. PMID: 2061442 Clinical Trial.

3

Association of Pityrosporum orbiculare (Malassezia furfur) with seborrheic dermatitis in patients with acquired immunodeficiency syndrome (AIDS).

Groisser D, Bottone EJ, Lebwohl M. Groisser D, et al. J Am Acad Dermatol. 1989 May;20(5 Pt 1):770-3. doi: 10.1016/s0190-9622(89)70088-8. J Am Acad Dermatol. 1989. PMID: 2523907

4

Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris.

Lucky AW, Henderson TA, Olson WH, Robisch DM, Lebwohl M, Swinyer LJ. Lucky AW, et al. J Am Acad Dermatol. 1997 Nov;37(5 Pt 1):746-54. doi: 10.1016/s0190-9622(97)70112-9. J Am Acad Dermatol. 1997. PMID: 9366821 Clinical Trial.

5

Once-daily tazarotene gel versus twice-daily fluocinonide cream in the treatment of plaque psoriasis.

Lebwohl M, Ast E, Callen JP, Cullen SI, Hong SR, Kulp-Shorten CL, Lowe NJ, Phillips TJ, Rosen T, Wolf DI, Quell JM, Sefton J, Lue JC, Gibson JR, Chandraratna RA. Lebwohl M, et al. J Am Acad Dermatol. 1998 May;38(5 Pt 1):705-11. doi: 10.1016/s0190-9622(98)70594-8. J Am Acad Dermatol. 1998. PMID: 9591815 Clinical Trial.

6

Calcipotriene ointment and halobetasol ointment in the long-term treatment of psoriasis: effects on the duration of improvement.

Lebwohl M, Yoles A, Lombardi K, Lou W. Lebwohl M, et al. J Am Acad Dermatol. 1998 Sep;39(3):447-50. doi: 10.1016/s0190-9622(98)70323-8. J Am Acad Dermatol. 1998. PMID: 9738781 Clinical Trial.

7

Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis.

Lebwohl MG, Breneman DL, Goffe BS, Grossman JR, Ling MR, Milbauer J, Pincus SH, Sibbald RG, Swinyer LJ, Weinstein GD, Lew-Kaya DA, Lue JC, Gibson JR, Sefton J. Lebwohl MG, et al. J Am Acad Dermatol. 1998 Oct;39(4 Pt 1):590-6. doi: 10.1016/s0190-9622(98)70008-8. J Am Acad Dermatol. 1998. PMID: 9777766 Clinical Trial.

8

Tazarotene in combination with topical corticosteroids.

Lebwohl M, Poulin Y. Lebwohl M, et al. J Am Acad Dermatol. 1998 Oct;39(4 Pt 2):S139-43. doi: 10.1016/s0190-9622(98)70311-1. J Am Acad Dermatol. 1998. PMID: 9777792 Review.

9

Acitretin in combination with UVB or PUVA.

Lebwohl M. Lebwohl M. J Am Acad Dermatol. 1999 Sep;41(3 Pt 2):S22-4. doi: 10.1016/s0190-9622(99)70362-2. J Am Acad Dermatol. 1999. PMID: 10459143 Review.

10

A comparison of once-daily application of mometasone furoate 0.1% cream compared with twice-daily hydrocortisone valerate 0.2% cream in pediatric atopic dermatitis patients who failed to respond to hydrocortisone: mometasone furoate study group.

Lebwohl M. Lebwohl M. Int J Dermatol. 1999 Aug;38(8):604-6. doi: 10.1046/j.1365-4362.1999.00759.x. Int J Dermatol. 1999. PMID: 10487451 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

691 results

Search Page